longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Lakewood-Amedex Biotherapeutics

LABT

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
All ShareholdersInstitutional HoldersInsiders

All Shareholders

Shareholder Type

  • Individuals & Insiders44.30%
  • Public and others38.25%
  • Private companies12.01%
  • Institutions5.44%

Major Shareholders

Major Shareholders Latest
Shareholder
Steve ParkinsonFormer CEO, President & Executive Director
19.69%466.61K47.01%+010/09/2025
Thomas Kaufmann
14.50%343.55K1.34%+1.0009/16/2026
Lindesfarne LLC
9.75%231.00K0.37%+27.64K09/16/2026
Royal Caswell
5.32%125.97K0.49%+1.0009/16/2026
TLP Management, LP
3.29%77.95K--+77.95K04/23/2026
Ted BrownFormer Non-Executive Director
3.27%77.55K107.58%-697.91K04/23/2026
Marex Group Limited
2.03%48.17K--+48.17K06/30/2026
Hudson River Trading LLC
1.89%44.78K--+44.78K06/30/2026
Bortel Investment Management, LLC
1.19%28.15K2.84%+010/09/2025
Peter CeccacciCFO & VP of Administration
0.47%11.13K0.04%+1.0009/16/2026
Leonard DeromaIndependent Director
0.31%7.46K0.03%+1.0009/16/2026
Douglas ManionIndependent Chairman
0.22%5.18K0.02%+1.0009/16/2026
UBS Asset Management AG
0.17%4.10K--+4.10K06/30/2026
Geode Capital Management, LLC
0.06%1.49K<0.01%+007/31/2026
Tower Research Capital Europe Limited
0.03%624.00--+624.0006/30/2026
Osaic Wealth, Inc.
<0.01%138.00--+138.0006/30/2026
Thrivent Trust Co.
<0.01%11.00--+11.0006/30/2026
Kelvin CooperCEO, SVP of Research & Development and Director
0.00%0.000.00%+004/23/2026
Thomas BalzerChief Medical Officer & SVP of Clinical Development
0.00%0.000.00%+004/23/2026